Clinical Trials Browser

INDUSTRY × Carcinoma, Hepatocellular × Folfox protocol × Clear all

NCT05033522 2025-10-23

ALIVE

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05864105 2025-03-12

PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT02069041 2018-11-21

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Phase 1 Completed

8 enrolled 16 charts

Gastrointestinal

Carcinoma, Hepatocellular